NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Tech solutions will address private prescription data deficit – DoH

By Catherine Reilly - 25th Oct 2022

controlled drugs

The introduction of technology-enabled solutions as part of the e-health strategy will help capture data on private prescriptions of controlled drugs, the Department of Health anticipates. 

The lack of data on private prescriptions of medications, such as opioids and benzodiazepines, was discussed at length last year by a Medical Council working group developing strategies to address overprescribing. 

At a meeting of the working group in March 2021, “the point was made that it can be difficult to get a full view on the prescribing of controlled drugs as currently private prescribing is not captured centrally”, according to minutes obtained by the Medical Independent (MI)

“There was a discussion with the representative from the Department of Health who said she was aware that this topic had been discussed for some time and from the Department’s perspective, if legislative change is being suggested then the Department needs to know that all of the different pros and cons of a proposal have been considered.” 

According to minutes, it was emphasised “that the legislative changes are required as the current situation just doesn’t make sense and that patient safety is at stake if this change doesn’t happen. It was acknowledged that the change does need to happen, but how it is done will need to be agreed.” 

Asked about progress on this matter, a Department of Health spokesperson informed MI: “The Department is continuing to participate in the Medical Council overprescribing working group with other stakeholders and is working towards resolving issues identified by this group with relevant responsible stakeholders. It is anticipated that the introduction of technology-enabled solutions as part of the e-health strategy will offer opportunities that will help to resolve data issues raised at this working group.” 

Leave a Reply

Latest Issue
The Medical Independent 26th September 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read